Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Concurrent Active and Passive Tetanus Immunization
NCT00437671Phase 4Terminated
- Sponsor
- Grifols
- Start
- Mar 2007
- Primary completion
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Tetanus immune globulin in Tetanus, sponsored by Grifols. Started Mar 2007; status: terminated.
02
Drugs
Tetanus immune globulin
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT00437671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437671.